Rising Chronic Diseases in Elderly Population and Government Support to Drive Geriatric Medicines Market USD 659 Billion by 2020

Rising Chronic Diseases in Elderly Population and Government Support to Drive Geriatric Medicines Market USD 659 Billion by 2020

Geriatric Medicines Market – Global Geriatric Indications and Therapeutics Analysis and Forecast 2016-2020, estimates the global geriatric medicines market to reach nearly USD 659 Billion in 2020, expanding at a CAGR of 7.5% from 2016 to 2020 – iHealthcareAnalyst, Inc.

Visit the Geriatric Medicines Market – Global Geriatric Indications and Therapeutics Analysis and Forecast 2016-2020 report at https://www.ihealthcareanalyst.com/report/geriatric-care-services-market/

Geriatric medicine is a subspecialty of internal medicine or family medicine that deals with the complex medical and psychosocial problems of older adults, and it is rapidly evolving into both a hospital-based specialty and a specialty concerned with community care. The geriatric medicines market report estimates the market size (Revenue USD million – 2013 to 2020) for key market segments based on the indication types (arthritis, cancer, cardiovascular, neurological, osteoporosis, respiratory, etc.), and therapeutic areas (analgesics, anticoagulants, antidiabetic, antihypertensive, antipsychotics, proton pump inhibitors, statins, etc.), and forecasts growth trends (CAGR% – 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, major products and services offered, and recent trends in strategic management.

The global geriatric medicines market is segmented as:

  1. Indication Type
    • Arthritis
    • Cancer
    • Cardiovascular
    • Neurological
    • Osteoporosis
    • Respiratory
    • Others
  1. Therapeutic Area
    • Analgesics
    • Anticoagulants
    • Antidiabetic
    • Antihypertensive
    • Antipsychotics
    • Proton Pump Inhibitors
    • Statins
    • Others
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories, Inc.
    • AstraZeneca plc.
    • Boehringer Ingelheim GmbH
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • GlaxoSmithKline Plc.
    • Merck & Company Inc.
    • Novartis AG
    • Pfizer, Inc.
    • Sanofi S.A

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2016-10-14T06:19:45+00:00 Categories: Press Releases|